During the past decade, Revival Research Institute, LLC conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Revival Research Institute, LLC" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Alfasigma S.p.A." with 1 trials sponsored and "AstraZeneca" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Revival Research Institute, LLC" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator, "United States Department of Defense" with 1 trials as a collaborator and "Vir Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Revival Research Institute, LLC" are "Atopic Dermatitis" (3 trials), "Acne Inversa" (2 trials), "COVID-19" (2 trials), "Alzheimer Disease" (1 trials) and "Chronic Cutaneous Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Revival Research Institute, LLC" in a lesser frequency.

Most popular intervention types in "Revival Research Institute, LLC" are "Drug" (14 trials), "Biological" (4 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Abrocitinib 200 mg" (2 trials), "Abrocitinib 100 mg" (1 trials), "BIIB059 (litifilimab)" (1 trials) and "Bamlanivimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Revival Research Institute, LLC" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Revival Research Institute, LLC". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Revival Research Institute, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Revival Research Institute, LLC, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".